LandsteinerK.WienerA. S.: Agglutinable Factor in Human Blood Recognized by Immune Sera for Rhesus Blood. Proc. Soc. for Exper. Biol. and Med.43:223 (Jan.) 1940.
2.
LevineP.: The Role of Isoimmunization in the Pathogenesis of Erythroblastosis Fetalis. Amer. Jour. Ob. and Gyn.42:925–37 (Dec.) 1941.
3.
PotterEdith L.: The Present Status of the Rh Factor. Amer. Jour. Dis. Child.68:32–58 (July) 1944.
4.
LandeLottie: Clinical Signs and Development of Survivors of Kernicterus Due to Rh Sensitization. Jour. of Ped.32:693–705 (June) 1948.
5.
DocterJack M.: Kernicterus. Neurological Sequelae of Erythroblastosis Fetalis. Jour. of Ped.27:327–44 (Oct.) 1945.
6.
DiamondLouis: The Clinical Importance of the Rh Blood Type. New Eng. Jour. Med.232:447–75 (Apr.) 1945.
7.
SturgeonPhillip: Immunohematologic Observations on Erythroblastotic Infants. Ped.3:318, 1949.
8.
GoodhillVictor: Clinical Pathologic Aspects of Kernicteric Nuclear 'Deafness'. Jour. Speech and Hearing Disorders21:407–412 (Dec.) 1956.
9.
LehrhoffIrwin: An Experimental Study of Auditory Threshold Acuity in Children with Cerebral Palsy by PGSR and Other Techniques. Annals of Otology, Rhinology and Laryngology67:3:643 (Sept.) 1958.
